| J9271 | Injection, pembrolizumab, 1 mg | 25,400 | $40 | $1.1M |
| J0897 | Injection, denosumab, 1 mg | 14,820 | $20 | $281.6K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 4,270 | $40 | $153.7K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 11,600 | $10 | $69.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,000 | $60 | $63.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 610 | $90 | $56.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 400 | $100 | $40K |
| Q5108 | Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | 320 | $100 | $30.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 130 | $140 | $17.1K |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 40 | $340 | $14.4K |